INS and type 2 diabetes mellitus: Finally, Acipimox inhibition of endogenous fatty acid availability reduced skeletal muscle fatty acyl‐CoA by 25%, concomitantly with increased whole‐body insulin sensitivity in males/females with T2D (Bajaj et al., 2005).